tiprankstipranks
Advertisement
Advertisement

LAB Stock Latest News

Standard BioTools Shareholders Approve 2026 Equity Incentive Plans
Company AnnouncementsStandard BioTools Shareholders Approve 2026 Equity Incentive Plans
22d ago
8K
LAB
Standard BioTools to Merge with Treeline Biosciences
PremiumCompany Announcements
Standard BioTools to Merge with Treeline Biosciences
1M ago
8K
LAB
Morning Movers: Corning jumps after optical supply deal with Amazon
PremiumThe Fly
Morning Movers: Corning jumps after optical supply deal with Amazon
1M ago
CPB
GHM
Standard BioTools, Treeline Biosciences to combine in all-stock transaction
PremiumThe Fly
Standard BioTools, Treeline Biosciences to combine in all-stock transaction
1M ago
LAB
ILMN
Standard BioTools Regains Nasdaq Minimum Bid Compliance Status
PremiumCompany Announcements
Standard BioTools Regains Nasdaq Minimum Bid Compliance Status
1M ago
8K
LAB
Standard BioTools Grants RSUs to Chief Business Officer
PremiumCompany AnnouncementsStandard BioTools Grants RSUs to Chief Business Officer
1M ago
8K
LAB
Standard BioTools Adopts New Executive Severance Protection Plans
Premium
Company Announcements
Standard BioTools Adopts New Executive Severance Protection Plans
1M ago
8K
LAB
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
Premium
Company Announcements
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
2M ago
LAB
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
PremiumCompany Announcements
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
2M ago
8K
LAB
Is LAB a Buy, Before Earnings?
PremiumPre-Earnings
Is LAB a Buy, Before Earnings?
2M ago
LAB
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany Announcements
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
3M ago
8K
LAB
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
PremiumRatings
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
5M ago
LAB
Standard BioTools Details SomaLogic Sale and Profitability Path
PremiumCompany AnnouncementsStandard BioTools Details SomaLogic Sale and Profitability Path
5M ago
8K
LAB
Standard BioTools reports Q4 EPS 5c vs (9c) last year
Premium
The Fly
Standard BioTools reports Q4 EPS 5c vs (9c) last year
5M ago
LAB
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
Premium
The Fly
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
5M ago
LAB
Is LAB a Buy, Before Earnings?
PremiumPre-Earnings
Is LAB a Buy, Before Earnings?
5M ago
LAB
Standard BioTools Completes Major Proteomics Business Divestiture
PremiumCompany Announcements
Standard BioTools Completes Major Proteomics Business Divestiture
5M ago
8K
LAB
Standard BioTools completes sale of SomaLogic to Illumina
PremiumThe Fly
Standard BioTools completes sale of SomaLogic to Illumina
5M ago
LAB
ILMN
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
PremiumThe Fly
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
6M ago
LAB
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
PremiumThe FlyStandard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
8M ago
LAB
Standard BioTools Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Standard BioTools Inc. Reports Q3 2025 Financial Results
8M ago
LAB
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
Premium
Ratings
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
8M ago
LAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >